period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.7,0.5,0.0,0.4166666666666667,[1],The FDA is aware of minor disruptions affecting a manufacturer. The current supply is adequate and patient safety is not at risk. We encourage stakeholders to report any significant changes.
1,1.5,0.7,0.8,0.0,0.5333333333333333,[1],The FDA is closely monitoring the emerging drug shortage situation. We encourage manufacturers and stakeholders to report any challenges they are facing to facilitate coordinated efforts in maintaining supply.
2,1.5,0.8500000000000001,0.6499999999999999,0.0,0.4333333333333333,[1],"The FDA is aware of and monitoring an emerging drug shortage. We encourage healthcare providers, manufacturers, and patients to report supply disruptions. Coordination efforts are underway to mitigate patient impacts."
3,1.5,1.0125,0.48750000000000004,0.012499999999999956,0.325,[1],The FDA is aware of an emerging drug shortage and is actively working with manufacturers and stakeholders to resolve the issue. We encourage all partners to report status updates and potential production increases.
4,1.3,1.0125,0.2875000000000001,0.012499999999999956,0.2211538461538462,[1],The FDA is monitoring the emerging supply shortage. We encourage manufacturers and distributors to report any supply disruptions to facilitate timely resolution.
5,1.2,1.0125,0.1875,0.012499999999999956,0.15625,[1],The FDA is aware of emerging supply issues within the market. We encourage manufacturers to report any disruptions and buyers to remain informed of official communications for updates. We are closely monitoring the situation.
6,1.2,1.0125,0.1875,0.012499999999999956,0.15625,[1],The FDA is closely monitoring the current drug supply situation. We encourage stakeholders to report any supply challenges. Coordination efforts are underway to mitigate potential disruptions.
